This result is consistent with our observation of defective cell cycle progression in JQ1-treated medulloblastoma cell lines (Fig. 2D) as well as the dramatic supression of CCND1 expression in HD-MB3 cells treated in time course (Fig. 3E). Here, CCND1 is linked to medulloblastoma.